Regulators are reviewing what could become a multi-billion-dollar drug.

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

In pursuit of innovation and cost control, legal departments are increasingly focused on establishing pre-approved ... at 13:05 Mevion Delivers Wisconsin's First Compact Proton Therapy System to MCW ...